What does Ascletis invest in?
Ascletis invests most often at Series E (100% of the rounds on record), in sectors such as Agriculture, Food And Beverage and Health Care.

United States · Investor
Last cheque observed Feb 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equity
1 rounds on record
Mostly Series E: 100% of its rounds
Sole investor in 1 rounds, median $18M
Every round we can evidence, newest first1 appearances
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Ascletis invests most often at Series E (100% of the rounds on record), in sectors such as Agriculture, Food And Beverage and Health Care.
1 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2019.
Its most recent investments on record: 3-V Biosciences (Series E, Feb 2019).
The median round it joins is $18M.
No investments in the last 12 months; the latest was in Feb 2019.
Ascletis is a growth equity firm based in United States.
Ascletis was founded in 2011.
From 1 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it